首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >MiR-203 inhibits estrogen-induced viability migration and invasion of estrogen receptor α-positive breast cancer cells
【2h】

MiR-203 inhibits estrogen-induced viability migration and invasion of estrogen receptor α-positive breast cancer cells

机译:MiR-203抑制雌激素诱导的雌激素受体α阳性乳腺癌细胞的生存能力迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Breast cancer is common in females, and accounts for a large proportion of cancer-related cases of mortality. MicroRNAs (miRs) have been found to be involved in the progression of breast cancer via mediation of tumor suppressor genes or oncogenes. Previously, miR-203 has been reported to play a suppressive role in breast cancer. In the present study, the effects of miR-203 on the malignant phenotypes of estrogen receptor α (ERα)-positive breast cancer cells were investigated. It was found that treatment with estradiol (E2) significantly enhanced the viability, migration and invasion of ERα-positive breast cancer MCF-7 cells, accompanied by the significant downregulation of miR-203 in a dose-dependent manner. Furthermore, MCF-7 cells were transfected with miR-203 mimics, resulting in a significant increase in miR-203 levels. Upregulation of miR-203 was found to significantly inhibit E2-induced upregulation of MCF-7 cell viability, migration and invasion. Upregulation of miR-203 also led to a significant decrease in the protein expression of ERα in MCF-7 cells. Using a luciferase reporter assay, ERα was identified as a direct target of miR-203 in MCF-7 cells. Finally, it was demonstrated that miR-203 was significantly downregulated in ERα-positive breast cancer tissues compared to their matched normal adjacent tissues. The expression levels of miR-203 were inversely correlated to the ERα levels in ERα-positive breast cancer tissues. Based on these results, it is proposed that miR-203 inhibits E2-induced viability, migration and invasion of ERα-positive breast cancer cells, and that this may be via direct targeting of ERα. Therefore, the present study highlights the importance of miR-203 and ERα in breast cancer progression.
机译:乳腺癌在女性中很常见,占癌症相关死亡率的很大一部分。发现MicroRNA(miRs)通过肿瘤抑制基因或癌基因的介导参与了乳腺癌的发展。以前,有报道说miR-203在乳腺癌中起抑制作用。在本研究中,研究了miR-203对雌激素受体α(ERα)阳性乳腺癌细胞恶性表型的影响。发现用雌二醇(E2)治疗显着增强了ERα阳性乳腺癌MCF-7细胞的活力,迁移和侵袭,同时以剂量依赖性方式显着下调了miR-203。此外,用miR-203模拟物转染了MCF-7细胞,导致miR-203水平显着增加。发现miR-203的上调显着抑制了E2诱导的MCF-7细胞活力,迁移和侵袭的上调。 miR-203的上调也导致MCF-7细胞中ERα的蛋白表达显着下降。使用萤光素酶报告基因测定法,ERα被鉴定为MCF-7细胞中miR-203的直接靶标。最后,证明了与ERα阳性乳腺癌组织相比,miR-203在ERα阳性乳腺癌组织中明显下调。 miR-203的表达水平与ERα阳性乳腺癌组织中的ERα水平成反比。基于这些结果,提出miR-203抑制E2诱导的ERα阳性乳腺癌细胞的生存力,迁移和侵袭,并且这可能是通过直接靶向ERα。因此,本研究强调了miR-203和ERα在乳腺癌进展中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号